Literature DB >> 1574038

Partial response after intensive chemotherapy for adrenal cortical carcinoma in a child.

M Aricò1, G Bossi, C Livieri, E Raiteri, F Severi.   

Abstract

Adrenocortical carcinoma (ACC) in childhood is a rare tumor with high fatality rate. Available reports provide event free survival rates ranging between 10 to 50%. Optimal treatment has not yet been established; surgery plays a major role, and the value of adjuvant chemotherapy needs to be evaluated further, especially in children who develop recurrent disease and those with metastases at diagnosis. Optimal therapy of ACC has not been established. Surgery has been curative after complete tumor resection. Children with inoperable, recurrent and metastatic ACC have been treated with O,P'DDD, with response rates ranging from 10 to 60% in different series [7,11-20]. Radiotherapy [21] and other anti-cancer drugs have been used [4-22] but their efficacy has not been established. Combination chemotherapy containing oncovin, cisPlatinum, epipodophyllotoxin and cyclophosphamide (OPEC) produced regression of metastatic ACC in a 5-year-old male [23]. We report one girl with relapsed disseminated ACC who showed good, even if temporary, control of the disease, with disappearance of lung, liver and spleen metastases, and marked reduction of the adrenal mass, following combined chemotherapy according to the "eight-drugs-in-one-day" protocol.

Entities:  

Mesh:

Year:  1992        PMID: 1574038     DOI: 10.1002/mpo.2950200314

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  5 in total

1.  Selective testosterone secreting adrenocortical carcinoma in an infant.

Authors:  S B Bavdekar; R R Kasla; R C Parmar; G S Hathi
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

2.  Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer.

Authors:  Tanweera S Khan; Anders Sundin; Claes Juhlin; Erik Wilander; Kjell Oberg; Barbro Eriksson
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

3.  Virilizing adrenal carcinoma in a 3-year-old boy: A rarity.

Authors:  Suresh Kumar; Punit Tiwari; Ranjeet Kr Das; Anup Kr Kundu
Journal:  Indian J Med Paediatr Oncol       Date:  2010-01

Review 4.  Virilizing Adrenocortical Carcinoma Invading the Right Atrium with Histological High-Grade Malignancy and p53 Mutation in a 3-Year-Old Child: Indication of Post Operative Adjuvant Chemotherapy.

Authors:  Keisuke Nagasaki; Reiko Horikawa; Jun-Ichi Nagaishi; Toshiro Honna; Akihiko Sekiguchi; Yukiko Tsunematsu; Toshiaki Tanaka
Journal:  Clin Pediatr Endocrinol       Date:  2004-07-07

5.  Rare Presentation of Adrenocortical Carcinoma in a 4-Month-Old Boy.

Authors:  Sonali Malhotra; Apoorva R Waikar; Prabhsimranjot Singh; Ludovico Guarini; Elka Jacobson-Dickman; Roja Motaghedi; Irina Kazachkova
Journal:  World J Oncol       Date:  2017-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.